期刊文献+

1例老年肺癌患者的药学监护

Pharmaceutical Care for a Case of Elderly Patient with Lung Cancer
下载PDF
导出
摘要 目的探讨临床药师如何对老年肺癌患者实施药学监护。方法临床药师在患者住院期间的药物治疗过程中对其进行药学监护,包括化疗方案的制订与评价,药物不良反应的监测,抗感染治疗药物的选择,同时对患者进行用药教育。结果通过临床药师的药学监护,患者化疗过程中获得个体化的治疗方案,提高了药物治疗效果,减少了药物损害,使患者顺利完成治疗。结论临床药师对患者进行药学监护,与临床医师密切合作,可进一步优化治疗方案,确保临床合理用药。 Objective To explore how to carry out pharmaceutical care for an elderly patient with lung cancer. Methods Clinical pharmacists provided pharmaceutical care for the patient in the whole therapy process, including making and evaluating chemotherapy regimens, monitoring the adverse drug reactions, selecting anti-bacterial drugs and providing pharmaceutical education for the patient. Results The pharmaceutical care provided by clinical pharmacists offered the patient with the individualized chemotherapy regimen, improved the therapeutic effects of medication and reduced the damage from medicines. Conclusion Clinical pharmacists work closely with doctors could optimize the therapeutic regimen and ensure the clinical rational drug use.
作者 孔薇 傅昌芳
出处 《肿瘤药学》 CAS 2015年第2期156-160,共5页 Anti-Tumor Pharmacy
关键词 临床药师 老年 非小细胞肺癌 化疗 药学监护 Clinical pharmacists Elderly NSCLC Chemotherapy Pharmaceutical care
  • 相关文献

参考文献13

  • 1Feday J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 vl.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [ EB/OL ]. Lyon, France: International Agency for Research on Cancer, 2013. http://globocan.iare. fr/Pages/faet_sheets_caneer.aspx. 被引量:1
  • 2Gkiozos I, Charpidou A, Syrigos K. Developments in the treatment of non-small cell lung cancer [J]. Anticancer Res, 2007, 27(4C): 2823-2827. 被引量:1
  • 3Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual [M]. 7 th Ed. Newyork: Springer, 2010: 253-270. 被引量:1
  • 4NCCN. NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer Vision 1 [ EB/OL ]. 2014. http://www.nccn.org/patients/. 被引量:1
  • 5Pallis AG, Gridelli C, Wedding U, et al. Management of elderly patients with NSCLC; updated expert' s opinion paper:EORTC Elderly Task Force, Lung Cancer Group and Inter- national Society for Geriatric Oncology [J] Ann Oncol, 2014, 25(7): 1270-1283. 被引量:1
  • 6Reck M, Popat S, Reinmuth N, et al. Metastatic non-small- cell lung cancer (NSCLC): ESMO Clinical Practice Guide- lines for diagnosis, treatment and follow-up [J]. Ann Oncol, 2014, 25 Suppl 3: iii27-39,. 被引量:1
  • 7张春来,梁颖,李明毅,左万里,黄炎明.吉西他滨联合卡铂对照奈达铂一线方案治疗晚期非小细胞肺癌临床研究[J].中国现代医药杂志,2011,13(6):48-50. 被引量:1
  • 8Scagliotti GV, Parikh P, yon Pawel J, et al. Phase Ⅲ study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced- stage non-small-cell lung cancer [J]. J Clin Oncol. 2008, 26(21): 3543-3551. 被引量:1
  • 9缪璐璐,范云,黄志煜,林能明,罗吕宏,余海峰.吉西他滨调整方案治疗晚期非小细胞肺癌的Ⅱ期临床试验[J].中国肺癌杂志,2012,15(1):1-5. 被引量:13
  • 10朱斌,余波,翟青.影响肿瘤患者化疗疗效的医源性因素分析[J].中国药房,2012,23(14):1327-1329. 被引量:7

二级参考文献21

共引文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部